Unknown

Dataset Information

0

Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases.


ABSTRACT: Hypoxia-inducible factors (HIFs) are stabilized during adverse inflammatory processes associated with disorders such as inflammatory bowel disease, pathogen infection and acute lung injury, as well as during ischaemia-reperfusion injury. HIF stabilization and hypoxia-induced changes in gene expression have a profound impact on the inflamed tissue microenvironment and on disease outcomes. Although the mechanism that initiates HIF stabilization may vary, the final molecular steps that control HIF stabilization converge on a set of oxygen-sensing prolyl hydroxylases (PHDs) that mark HIFs for proteasomal degradation. PHDs are therefore promising therapeutic targets. In this Review, we discuss the emerging potential and associated challenges of targeting the PHD-HIF pathway for the treatment of inflammatory and ischaemic diseases.

SUBMITTER: Eltzschig HK 

PROVIDER: S-EPMC4259899 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3787797 | BioStudies
1000-01-01 | S-EPMC3895861 | BioStudies
2016-01-01 | S-EPMC5007464 | BioStudies
2015-01-01 | S-EPMC4492579 | BioStudies
1000-01-01 | S-EPMC2795511 | BioStudies
2018-01-01 | S-EPMC6235002 | BioStudies
2012-01-01 | S-EPMC3260409 | BioStudies
1000-01-01 | S-EPMC5106373 | BioStudies
2008-01-01 | S-EPMC2290777 | BioStudies
1000-01-01 | S-EPMC3133367 | BioStudies